Product Information
METRONIDAZOLE 500 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1005 per EA under NDC 16571066401. Its NADAC has been published 317 times since Jun 3, 2020.
Strength
500 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571066401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203974On Market Since
5/29/2015
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 500 MG TABLET has been published 317 times since Jun 3, 2020, and over the history we have for it it has declined 24.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1005 per EA |
|---|---|
| All-time high | $0.2130 (Dec 16, 2020) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1102 |
| 52-week low | $0.0999 |
| Median price | $0.1328 |
| Average price | $0.1317 |
| Largest weekly change | +39.1% (Jun 19, 2024) |
| Weeks tracked | 317 |
| Tracking since | Jun 3, 2020 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 500 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1005 per EA (NDC 16571066401), effective Jun 24, 2026.
How has the price of METRONIDAZOLE 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 500 MG TABLET has declined 24.0%. It has been tracked across 317 weekly CMS publications since Jun 3, 2020.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 500 MG TABLET?
Since Jun 3, 2020, the NADAC for METRONIDAZOLE 500 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.2130 (Dec 16, 2020), with a median of $0.1328 per EA.
Are there cheaper alternatives to METRONIDAZOLE 500 MG TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as METRONIDAZOLE 500 MG TABLET, but none are currently priced below it.
Who manufactures METRONIDAZOLE 500 MG TABLET?
METRONIDAZOLE 500 MG TABLET (NDC 16571066401) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification